Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases
Skin inflammation occurs due to immune dysregulation because of internal disorders, infections, and allergic reactions. The inflammation of the skin is a major sign of chronic autoimmune inflammatory diseases, such as psoriasis, atopic dermatitis (AD), and lupus erythematosus. Although there are man...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-08-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/12/8/1072 |
| _version_ | 1797432425695936512 |
|---|---|
| author | Shih-Chun Yang Ahmed Alalaiwe Zih-Chan Lin Yu-Chih Lin Ibrahim A. Aljuffali Jia-You Fang |
| author_facet | Shih-Chun Yang Ahmed Alalaiwe Zih-Chan Lin Yu-Chih Lin Ibrahim A. Aljuffali Jia-You Fang |
| author_sort | Shih-Chun Yang |
| collection | DOAJ |
| description | Skin inflammation occurs due to immune dysregulation because of internal disorders, infections, and allergic reactions. The inflammation of the skin is a major sign of chronic autoimmune inflammatory diseases, such as psoriasis, atopic dermatitis (AD), and lupus erythematosus. Although there are many therapies for treating these cutaneous inflammation diseases, their recurrence rates are high due to incomplete resolution. MicroRNA (miRNA) plays a critical role in skin inflammation by regulating the expression of protein-coding genes at the posttranscriptional level during pathogenesis and homeostasis maintenance. Some miRNAs possess anti-inflammatory features, which are beneficial for mitigating the inflammatory response. miRNAs that are reduced in inflammatory skin diseases can be supplied transiently using miRNA mimics and agomir. miRNA-based therapies that can target multiple genes in a given pathway are potential candidates for the treatment of skin inflammation. This review article offers an overview of the function of miRNA in skin inflammation regulation, with a focus on psoriasis, AD, and cutaneous wounds. Some bioactive molecules can target and modulate miRNAs to achieve the objective of inflammation suppression. This review also reports the anti-inflammatory efficacy of these molecules through modulating miRNA expression. The main limitations of miRNA-based therapies are rapid biodegradation and poor skin and cell penetration. Consideration was given to improving these drawbacks using the approaches of cell-penetrating peptides (CPPs), nanocarriers, exosomes, and low-frequency ultrasound. A formulation design for successful miRNA delivery into skin and target cells is also described in this review. The possible use of miRNAs as biomarkers and therapeutic modalities could open a novel opportunity for the diagnosis and treatment of inflammation-associated skin diseases. |
| first_indexed | 2024-03-09T10:00:21Z |
| format | Article |
| id | doaj.art-52a25a64258c45c3acd7003935db2615 |
| institution | Directory Open Access Journal |
| issn | 2218-273X |
| language | English |
| last_indexed | 2024-03-09T10:00:21Z |
| publishDate | 2022-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomolecules |
| spelling | doaj.art-52a25a64258c45c3acd7003935db26152023-12-01T23:28:59ZengMDPI AGBiomolecules2218-273X2022-08-01128107210.3390/biom12081072Anti-Inflammatory microRNAs for Treating Inflammatory Skin DiseasesShih-Chun Yang0Ahmed Alalaiwe1Zih-Chan Lin2Yu-Chih Lin3Ibrahim A. Aljuffali4Jia-You Fang5Department of Microbiology, Soochow University, Taipei 111, TaiwanDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi ArabiaPharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan 333, TaiwanDepartment of Environmental Engineering and Health, Yuanpei University, Hsinchu 300, TaiwanDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11362, Saudi ArabiaPharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan 333, TaiwanSkin inflammation occurs due to immune dysregulation because of internal disorders, infections, and allergic reactions. The inflammation of the skin is a major sign of chronic autoimmune inflammatory diseases, such as psoriasis, atopic dermatitis (AD), and lupus erythematosus. Although there are many therapies for treating these cutaneous inflammation diseases, their recurrence rates are high due to incomplete resolution. MicroRNA (miRNA) plays a critical role in skin inflammation by regulating the expression of protein-coding genes at the posttranscriptional level during pathogenesis and homeostasis maintenance. Some miRNAs possess anti-inflammatory features, which are beneficial for mitigating the inflammatory response. miRNAs that are reduced in inflammatory skin diseases can be supplied transiently using miRNA mimics and agomir. miRNA-based therapies that can target multiple genes in a given pathway are potential candidates for the treatment of skin inflammation. This review article offers an overview of the function of miRNA in skin inflammation regulation, with a focus on psoriasis, AD, and cutaneous wounds. Some bioactive molecules can target and modulate miRNAs to achieve the objective of inflammation suppression. This review also reports the anti-inflammatory efficacy of these molecules through modulating miRNA expression. The main limitations of miRNA-based therapies are rapid biodegradation and poor skin and cell penetration. Consideration was given to improving these drawbacks using the approaches of cell-penetrating peptides (CPPs), nanocarriers, exosomes, and low-frequency ultrasound. A formulation design for successful miRNA delivery into skin and target cells is also described in this review. The possible use of miRNAs as biomarkers and therapeutic modalities could open a novel opportunity for the diagnosis and treatment of inflammation-associated skin diseases.https://www.mdpi.com/2218-273X/12/8/1072microRNAskinanti-inflammationinflammatory diseasekeratinocyte |
| spellingShingle | Shih-Chun Yang Ahmed Alalaiwe Zih-Chan Lin Yu-Chih Lin Ibrahim A. Aljuffali Jia-You Fang Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases Biomolecules microRNA skin anti-inflammation inflammatory disease keratinocyte |
| title | Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases |
| title_full | Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases |
| title_fullStr | Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases |
| title_full_unstemmed | Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases |
| title_short | Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases |
| title_sort | anti inflammatory micrornas for treating inflammatory skin diseases |
| topic | microRNA skin anti-inflammation inflammatory disease keratinocyte |
| url | https://www.mdpi.com/2218-273X/12/8/1072 |
| work_keys_str_mv | AT shihchunyang antiinflammatorymicrornasfortreatinginflammatoryskindiseases AT ahmedalalaiwe antiinflammatorymicrornasfortreatinginflammatoryskindiseases AT zihchanlin antiinflammatorymicrornasfortreatinginflammatoryskindiseases AT yuchihlin antiinflammatorymicrornasfortreatinginflammatoryskindiseases AT ibrahimaaljuffali antiinflammatorymicrornasfortreatinginflammatoryskindiseases AT jiayoufang antiinflammatorymicrornasfortreatinginflammatoryskindiseases |